|
|
||||||||
J Thorac Cardiovasc Surg 2007;133:1685-1686
© 2007 The American Association for Thoracic Surgery
Letter to the Editor |
Department of Cardiology, University of Maastricht, Maastricht, The Netherlands
| The first 20% of the full text of this article appears below. |
To the Editor:
We read with great interest the article by Boodhwani and colleagues1
regarding the impact of high-dose statin therapy on vascular endothelial growth factor-A (VEGF-A)induced myocardial angiogenesis in a hypercholesterolemic pig model of chronic ischemia. This article demonstrated that collateral-dependent myocardial perfusion remained impaired in hypercholesterolemic and atorvastatin-treated pigs in response to additional treatment with VEGF-A relative to a normocholesterolemic control group. It concluded that a high-dose statin therapy was not associated with improved myocardial neovascularization. In that study, however, the hypercholesterolemic pigs
Related Article
J. Thorac. Cardiovasc. Surg. 2007 133: 1686-1687.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |